Home Cart 0 Sign in  
X

[ CAS No. 129872-81-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 129872-81-7
Chemical Structure| 129872-81-7
Chemical Structure| 129872-81-7
Structure of 129872-81-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 129872-81-7 ]

Related Doc. of [ 129872-81-7 ]

Alternatived Products of [ 129872-81-7 ]

Product Details of [ 129872-81-7 ]

CAS No. :129872-81-7 MDL No. :MFCD12755925
Formula : C7H5Cl2N3 Boiling Point : -
Linear Structure Formula :- InChI Key :LYUFQUBRAUGFLK-UHFFFAOYSA-N
M.W : 202.04 Pubchem ID :14727763
Synonyms :

Calculated chemistry of [ 129872-81-7 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.14
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 48.81
TPSA : 30.71 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.91 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.3
Log Po/w (XLOGP3) : 2.29
Log Po/w (WLOGP) : 2.28
Log Po/w (MLOGP) : 1.29
Log Po/w (SILICOS-IT) : 2.2
Consensus Log Po/w : 2.07

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.09
Solubility : 0.164 mg/ml ; 0.000812 mol/l
Class : Soluble
Log S (Ali) : -2.57
Solubility : 0.541 mg/ml ; 0.00268 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.34
Solubility : 0.0928 mg/ml ; 0.000459 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.78

Safety of [ 129872-81-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 129872-81-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 129872-81-7 ]
  • Downstream synthetic route of [ 129872-81-7 ]

[ 129872-81-7 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 63200-54-4 ]
  • [ 74-88-4 ]
  • [ 129872-81-7 ]
YieldReaction ConditionsOperation in experiment
91% With caesium carbonate In N,N-dimethyl-formamide at 20℃; for 24 h; 2,4-Dichloro-5H-pyrrolo [3,2-d] pyrimidine(600 mg, 3.19 mmol) was placed in a round bottom flask,N, N-dimethylformamide DMF (5 mL) was added to dissolve it,Methyl iodide (544 mg, 3.83 mmol) and cesium carbonate (520 mg, 1.60 mmol) were added successively and the reaction was stirred at room temperature for 24 h.Treatment: The reaction solution was added to water and extracted with ethyl acetate,The organic phase was collected, dried over anhydrous sodium sulphate, filtered off with suction and concentrated. A yellow solid. Yield: 91percent.
88% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 6 h; General procedure: Compound 20a (30 mg, 0.058 mmol) and K2CO3 (16 mg, 0.12 mmol) were added to a 2 mL solution of CH3I (21 mg, 0.15 mmol) in DMF. The mixture was stirred at room temperature for 6 h. The reaction mixture was quenched by adding water, followed by extracting with EtOAc. Then the organic phase was dried over anhydrous Na2SO4, and concentrated in vacuo. The resulting residue was purified via silica gel column chromatography using CH2Cl2/MeOH(100/1) to give 21a (31 mg, 100 percent) as a yellow solid.
86% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 2 h; Dissolve 5H-pyrrolo[3,2-d]pyrimidine (510 mg, 1 eq) in N,N-dimethylformamide (10 ml).Add iodomethane (1.93g, 5eq) and potassium carbonate (1.13g, 3eq) for 2h at room temperature, add water,Dichloromethane extraction, concentration,Dry to give a solid (497 mg, 86percent).
81% With caesium carbonate In water; N,N-dimethyl-formamide for 1.5 h; INTERMEDIATE 32 2,4-Dichloro-5 -methylpyrrolo [3 ,2-d]pyrimidine lodomethane (0.98 mL, 16 mmol) was added to a suspension of 2,4-dichloro-5H- pyrrolo[3,2-d]pyrimidine (3 g, 15.8 mmol) and cesium carbonate (5.14 g, 15.8 mmol) in DMF (50 mL). The reaction mixture was stirred for 1.5 h, then water was added. The resulting thick white precipitate was filtered off, then washed with water and isohexane. The residue was concentrated by evaporation to provide the title compound (2.58 g, 81percent)as a white solid. LCMS (ES+) [M+H] 202, 204, RT 1.13 minutes (method 1).
51%
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 0℃; for 0.5 h;
Stage #2: at 20℃;
[00348] To a solution of 2,4-dichloro-5H-pyrrolo[3,2-d]pyrimidine (500 mg, 2.66 mmol) in DMF (8 mL) was added NaH (127 mg, 3.19 mmol, 60percent) at 0 °C. The reaction mixture was stirred for 30 mm at 0 °C, then iodomethane (3.78 g, 26.60 mmol) was added. The reaction mixture was stirred at rt overnight. Water (50 mL) was added to quench the reaction, and the mixture was partitioned. The aqueous layer was extracted with EtOAc (50 mL x 2). The combined organic layers were washed with saturated brine (80 mL), dried over anhydrous Na2SO4 and filtered. The filtrate was concentrated in vacuo and the residue was purified by silica gel chromatograph (PE/EtOAc (v/v) = 10/1) to give the title compound as a yellow solid (275 mg, 51 percent).MS (ESI, pos. ion) m/z: 202.00 [M+H]+1H NMR (400 MHz, CDC13) (ppm): 7.47 (d, J = 3.1 Hz, 1H), 6.64 (d, J = 3.0 Hz, 1H), 4.16 (s, 3H).

Reference: [1] Patent: CN107312006, 2017, A, . Location in patent: Paragraph 0037-0039
[2] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 15, p. 3486 - 3492
[3] Patent: CN104177363, 2018, B, . Location in patent: Paragraph 0247; 0250-0251
[4] Patent: WO2015/193168, , A1, . Location in patent: Page/Page column 59[4] Patent: , 2015, , . Location in patent: Page/Page column 59
[6] Patent: WO2017/97234, 2017, A1, . Location in patent: Paragraph 00348
[7] Journal of Medicinal Chemistry, 1990, vol. 33, # 10, p. 2750 - 2755
[8] Patent: EP1956009, 2008, A1, . Location in patent: Page/Page column 39
[9] Patent: EP1970373, 2008, A1, . Location in patent: Page/Page column 95
  • 2
  • [ 77-78-1 ]
  • [ 63200-54-4 ]
  • [ 129872-81-7 ]
YieldReaction ConditionsOperation in experiment
70% With caesium carbonate In N,N-dimethyl-formamide at 20℃; for 5 h; Inert atmosphere Compound 1 (100 mg, 0.53 mmol), cesium carbonate (350 mg, 1.06 mmol) were dissolved in 1 ml DMF.
To the solution was added dimethyl sulfate (1 mL) in nitrogen atmosphere.
The resulting reaction liquid was stirred at room temperature for 5 hours.
The reaction was stopped.
To the reaction liquid was added slowly 50 mL of water.
After the system was cooled, added ethyl acetate, and the liquid was separated.
The organic phase was washed twice with saturated sodium chloride solution, dried over anhydride sodium sulfate, concentrated and purified by silica-gel column chromatography (petroleum ether/ethyl acetate=2/1) to yield compound 10 (white solid, 76.3 mg, yield 70percent), which was used directly for the reaction in next step.
MS (ESI) m/z: 203 [M+H]+.
Reference: [1] Patent: EP3290420, 2018, A1, . Location in patent: Paragraph 0067 - 0069
  • 3
  • [ 66-27-3 ]
  • [ 63200-54-4 ]
  • [ 129872-81-7 ]
Reference: [1] Patent: WO2012/82997, 2012, A1, . Location in patent: Page/Page column 85
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 129872-81-7 ]

Chlorides

Chemical Structure| 63200-54-4

[ 63200-54-4 ]

2,4-Dichloro-5H-pyrrolo[3,2-d]pyrimidine

Similarity: 0.96

Chemical Structure| 1923177-10-9

[ 1923177-10-9 ]

2,4,7-Trichloro-5H-pyrrolo[3,2-d]pyrimidine

Similarity: 0.84

Chemical Structure| 13162-27-1

[ 13162-27-1 ]

2,4-Dichloro-6-methylpyrimidin-5-amine

Similarity: 0.83

Chemical Structure| 1211536-93-4

[ 1211536-93-4 ]

6-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine

Similarity: 0.77

Chemical Structure| 1032650-41-1

[ 1032650-41-1 ]

7-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine

Similarity: 0.72

Related Parent Nucleus of
[ 129872-81-7 ]

Other Aromatic Heterocycles

Chemical Structure| 63200-54-4

[ 63200-54-4 ]

2,4-Dichloro-5H-pyrrolo[3,2-d]pyrimidine

Similarity: 0.96

Chemical Structure| 1923177-10-9

[ 1923177-10-9 ]

2,4,7-Trichloro-5H-pyrrolo[3,2-d]pyrimidine

Similarity: 0.84

Chemical Structure| 1211536-93-4

[ 1211536-93-4 ]

6-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine

Similarity: 0.77

Chemical Structure| 1032650-41-1

[ 1032650-41-1 ]

7-Bromo-4-chloro-5H-pyrrolo[3,2-d]pyrimidine

Similarity: 0.72

Chemical Structure| 923282-39-7

[ 923282-39-7 ]

7-Chloro-1-methyl-1H-pyrazolo[4,3-d]pyrimidine

Similarity: 0.67